Obsessive-compulsive disorder (OCD) Investigational Medication

  • STATUS
    Recruiting
  • participants needed
    10
Send
Updated on 19 February 2024

Summary

The Center for the Treatment and Study of Anxiety is offering an investigational medication for people who have obsessive-compulsive disorder (OCD) and are currently taking an SRI medication for their OCD but still have unwanted symptoms.

Description

The Center for the Treatment and Study of Anxiety is offering an investigational medication for people who have obsessive-compulsive disorder (OCD) and are currently taking one of the below medications for their OCD but still have unwanted symptoms. 



Are you taking one of the following medications for obsessive-compulsive disorder?


    • Clomipramine (Anafranil)
    • Fluoxetine (Prozac)
    • Fluvoxamine (Luvox)
    • Sertraline (Zoloft)
    • Paroxetine (Paxil)
    • Citalopram (Celexa)
    • Escitalopram (Lexapro)



 Eligible participants remain on a stable dose of their OCD medication in the first part of the study, and will receive an investigational medication or a placebo as additional treatment for 10 weeks. Individuals who do not improve will be referred elsewhere to receive appropriate clinical treatment.

 

Men and women ages 18-75 with OCD who are currently taking an SRI medication (Prozac, Zoloft, Paxil, Luvox, Celexa, Lexapro or Anafranil) may be eligible to participate in this study.  There is no cost for this study. Participants may be compensated to $525 for their participation.


FAQ

 If interested, contact Gina at gbelli@pennmedicine.upenn.edu to receive our initial eligibility screener.


Details
Condition OCD,Obessive Compulsive Disorder
Age 18years - 75years
Clinical Study IdentifierTX5918
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.